Aspergillosis: all 202 studies
Page 1 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- A Study of Itraconazole and Posaconazole for Chronic Pulmonary AspergillosisNot yet recruitingNCT07825259Phase 3
- Aspergillus Infection in Patients Admitted to Hematology WardRecruitingNCT07440485
- Isavuconazole in Critically Ill Patients: Efficacy and SafetyNot yet recruitingNCT07080359
- Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-beingRecruitingNCT06885905
- Multicenter Registration Study on Allergic Bronchopulmonary AspergillosisNot yet recruitingNCT06645210
- Individualized First Maintenance Doses of Voriconazole Through a Multiparametric AlgorithmNot yet recruitingNCT06582186Phase 4
- Breath Analysis for the Detection of Invasive Fungal InfectionsRecruitingNCT06537726
- Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in ChildrenRecruitingNCT06440915Not applicable
- Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation TherapyRecruitingNCT06382922
- Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant RecipientsRecruitingNCT06344117
- A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary AspergillosisRecruitingNCT06174922Phase 3
- Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis ExacerbationsRecruitingNCT06160713Phase 3
- Immune Regulation in Chronic Aspergillus Infection After COVID-19 InfectionRecruitingNCT06135597
- Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-studyRecruitingNCT06069505
- ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word StudyRecruitingNCT06028451
- VOC in Breath Samples for the Diagnosis of IPARecruitingNCT05982912
- Early Diagnosis of Invasive Lung AspergillosisRecruitingNCT05860387
- Impact of A. Lumbricoides on Pulmonary Aspergillosis DevelopmentRecruitingNCT05783544Not applicable
- PTX3-targeted Antifungal ProphylaxisRecruitingNCT03828773Not applicable
- Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold InfectionsRecruitingNCT03827694
- Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell TransplantsRecruitingNCT03717623Phase 4
- Chronic Pulmonary Aspergillosis and Ambisome Aerosol with ItraconazoleRecruitingNCT03656081Phase 3
- Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill PatientsCompletedNCT05065658Results posted
- Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)CompletedNCT04442269Phase 2Results posted
- Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare MoldsTerminatedNCT04240886Phase 2Results posted
- Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic SubjectsCompletedNCT04229303Phase 1Results posted
- Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)CompletedNCT04218851Phase 2Results posted
- A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric ParticipantsCompletedNCT03816176Phase 2Results posted
- Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary AspergillosisTerminatedNCT03672292Phase 2Results posted
- Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill PatientsCompletedNCT03378479Phase 4Results posted
- Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal TreatmentCompletedNCT03059992Phase 3Results posted
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)CompletedNCT02879305Phase 3Results posted
- Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy VolunteersCompletedNCT02631954Phase 1Results posted
- Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)CompletedNCT02180165Phase 3Results posted
- F901318 Single Ascending Dose Study in Healthy Male VolunteersCompletedNCT02142153Phase 1Results posted
- A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)CompletedNCT01782131Phase 3Results posted
- Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute LeukaemiaCompletedNCT01615809Phase 2Results posted
- Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal InfectionCompletedNCT01383993Phase 2Results posted
- Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary AspergillosisCompletedNCT01222273Not applicableResults posted
- A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)CompletedNCT01165320Phase 2Results posted
- A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy SubjectsCompletedNCT00940017Phase 4Results posted
- An Observational Study of Fungal Biomarkers (MK-0000-089)CompletedNCT00854607Results posted
- A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In ChildrenTerminatedNCT00836875Phase 3Results posted
- An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)TerminatedNCT00787917Phase 4Results posted
- A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal InfectionCompletedNCT00784368Phase 3Results posted
- A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)CompletedNCT00717860Phase 3Results posted
- Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare FungiCompletedNCT00634049Phase 3Results posted
- Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)TerminatedNCT00620074Phase 4Results posted
- Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive AspergillosisCompletedNCT00531479Phase 3Results posted
- Isavuconazole (BAL8557) for Primary Treatment of Invasive AspergillosisCompletedNCT00412893Phase 3Results posted
- Caspofungin Maximum Tolerated Dose in Patients With Invasive AspergillosisCompletedNCT00404092Phase 2Results posted
- Voriconazole For Chronic Bronchopulmonary AspergillosisCompletedNCT00159822Phase 2/3Results posted
- Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant RecipientsCompletedNCT06654076
- Treatment Duration of IPAActive, not recruitingNCT06583512
- Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center ExperienceCompletedNCT06564727Not applicable
- Risk of Aspergillus Infection in Patients With Chronic Lung DiseaseCompletedNCT06379568
- Aspergillosis Detection Via EBC-GM in Ventilated PatientsCompletedNCT06333379
- Allergic Bronchopulmonary Aspergillosis Prescreening StudyWithdrawnNCT05903612
- Voriconazole Inhalation Powder for the Treatment of Pulmonary AspergillosisNo longer availableNCT05897294
- A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusCompletedNCT05707832Phase 3
- Prospective Observational Study on the Incidence of Opportunistic Fungal InfectionsCompletedNCT05707156
- Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility StudyActive, not recruitingNCT05653193Phase 2
- LFD of Aspergillus Antigen in PaediatricsStatus unknownNCT05569824
- Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.Status unknownNCT05138666Not applicable
- A Prospective Study on Optimizing Treatment for ABPAStatus unknownNCT05129033Not applicable
- Pharmacological Evaluation of Antifungal in Chronic Pulmonary AspergillosisStatus unknownNCT05064605
- Pulmonary Aspergillosis in Tuberculosis PatientsActive, not recruitingNCT05045391
- A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus InfectionStatus unknownNCT04966234Phase 2/3
- Mucormycosis in COVID-19CompletedNCT04935463
- Azole-echinocandin Combination Therapy for Invasive AspergillosisTerminatedNCT04876716Phase 3
- Pharmacokinetics of Voriconazole in Adult ECMO PatientsCompletedNCT04868188
- Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar FluidStatus unknownNCT04848831
- A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary AspergillosisCompletedNCT04824417Phase 3
- COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)CompletedNCT04818853
- Physiotherapy Treatment Plan in Allergic Bronchopulmonary Aspergillosis: Case ReportCompletedNCT04748900
- Post Marketing Surveillance (PMS) Study of Cresemba in Korea.CompletedNCT04744454
- Aspergillosis and Humoral Alveolar Immunity by ProteomicsStatus unknownNCT04728763
- Isavuconazole for the Prevention of COVID-19-associated Pulmonary AspergillosisTerminatedNCT04707703Phase 3
- Immune Profiles in CF Fungal InfectionCompletedNCT04476758
- THYME AND CARVACROLL Nanoparticle Effect on FungiCompletedNCT04431804
- Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath CondensateCompletedNCT04358419
- Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)CompletedNCT04267497Phase 1
- Invasive Pulmonary Aspergillosis and Severe InfluenzaCompletedNCT04232956
- Deflazacort Vs. Prednisolone in Acute-stage ABPAActive, not recruitingNCT04227483Phase 2/3
- Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive AspergillosisStatus unknownNCT04225195Phase 2
- Prevalence of Influenza RelAted Invasive AspergillosisCompletedNCT04172610
- Benralizumab in the Treatment of Patients With Severe Asthma With ABPAWithdrawnNCT04108962Phase 4
- Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.CompletedNCT04077697
- Study in Adult Asthmatic Patients With Allergic Bronchopulmonary AspergillosisTerminatedNCT03960606Phase 2
- Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPACompletedNCT03920527Phase 3
- The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.TerminatedNCT03905447Phase 2
- The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic FibrosisTerminatedNCT03870841Phase 2
- The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory DiseasesTerminatedNCT03745196Phase 2
- CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood LevelsCompletedNCT03731169Phase 4
- Cytokine Profile of Allergic Bronchopulmonary AspergillosisStatus unknownNCT03643185
- Ampholipad Real-World Data in TaiwanCompletedNCT03641131
- Azole-resistance in AspergillusCompletedNCT03443336
- Invasive Pulmonary Aspergillosis Complicating Influenza InfectionCompletedNCT03391492
- Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive AspergillosisCompletedNCT03349931
- Assessment of Varying Oral Dosing Regimens for F901318 in Healthy SubjectsCompletedNCT03340597Phase 1